Rapafusyn is a company that appears to specialize in technology solutions. The name suggests a focus on rapid fusion of technology and data to provide innovative services or products.

Rapafusyn

Rapafusyn Pharmaceuticals is an emerging pharmaceutical development company located in Baltimore Maryland. Rapafusyn has licensed technology related to a novel class of natural product-like macrocycles from Johns Hopkins University School of Medicine and seeks to develop novel pharmaceuticals to treat patients having diseases and fulfill unmet medical  needs.

Rapafusyn Pharmaceuticals

Rapafusyn is pleased to announce two presentations at the Drug Discovery Chemistry Meeting, April 1 – 4 in San Diego. Dr. Rick Ewing, VP of Medicinal Chemistry, will be giving an oral presentation on Rapafusyn’s Non-Degradation Molecular Glue platform and Dr. Sam Hong will be presenting a poster on our industry leading libraries of molecular glues. Go to https://lnkd.in/dNkqe6qQ for more details.

Rapafusyn Pharmaceuticals is proud to announce Dr. Rick Ewing, Vice President of Medicinal Chemistry, has been recognized for his outstanding accomplishments with two distinguished awards. Rick has received both the 2023 American Chemical Society (ACS) Philadelphia Section Award, and the 2023 Edison Patent Award in Biotechnology – congratulations Rick! For more information go to https://lnkd.in/eGr94knP


Join us as we share innovative insights, groundbreaking solutions, and a vision for the future! 


Rapafusyn is thrilled to announce two presentations at the upcoming Molecular Glue Drug Discovery Summit, Jan 31 – Feb 1 in Boston. Dr. Rick Ewing, VP of Medicinal Chemistry, will be giving an oral presentation on Rapafusyn’s Non-Degradation Molecular Glue platform and Dr. Matthew Olson will be presenting a poster on our ENT1 program for the treatment of Acute Kidney Injury. Go to https://lnkd.in/dNkqe6qQ for more details.

Metric
Company Name	Rapafusyn
Symbol
MSH ID	COM:RAPAFUSYN
Market	PRIVATE
Sector	Technology
Industry	Technology
Country	US
Stage
Employee Count	10
Website	rapafusyn.com
LinkedIn	rapafusyn-pharmaceuticals
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	13.73
28-Day Growth Score	19.76
90-Day Growth Score	17.46
365-Day Growth Score	39.09

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:RAPAFUSYN

Rapafusyn

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue